Literature DB >> 350364

Incidence of the H2 group of plasmids in chloramphenicol-sensitive salmonella isolated in 1974 from clinical sources in Ontario.

D E Taylor, M Shermier, R B Grant.   

Abstract

Chloramphenicol resistance in salmonella obtained from clinical sources in Ontario was previously found to be often mediated by R plasmids of the H2 incompatibility group. In the present study 40 salmonella strains resistant to one or more of kanamycin, streptomycin, sulfonamides, or tetracycline but sensitive to chloramphenicol, were investigated to determine if they contained R plasmids. Self-transmissible plasmids were isolated from 17 of the strains, and 7 of those showed the bacteriophage inhibition and thermosensitive mechanism of transfer characteristic of H2 plasmids. Entry exclusion and incompatibility experiments confiremd their classification. The results demonstrate that in this population of salmonella, R plasmids of the H2 group are prevalent. Experiments with plasmid-specific phages indicate that the plasmids of this sample, which are not in the H2 group, do not belong to any of the F, I, N, P, or W incompatibility groups.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350364     DOI: 10.1139/m78-098

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  3 in total

1.  Characterization of a plasmid mutation affecting maintenance, transfer and elimination by novobiocin.

Authors:  D E Taylor; J G Levine
Journal:  Mol Gen Genet       Date:  1979-07-13

2.  Association of tellurium resistance and bacteriophage inhibition conferred by R plasmids.

Authors:  D E Taylor; A O Summers
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

3.  Diagnostic and public health dilemma of lactose-fermenting Salmonella enterica serotype Typhimurium in cattle in the Northeastern United States.

Authors:  P L McDonough; S J Shin; D H Lein
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.